WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

BENDAMUSTINE INDUCED ERYTHEMA MULTIFORMAE – A CASE REPORT

Swathi Bhat* and Anuradha HV

ABSTRACT

Introduction: Erythema multiformae (EM) is an uncommon, acute eruption characterized by fixed, targetoid skin lesions with or without mild mucosal lesions. It is a type IV hypersensitivity reaction to bacteria, virus, drugs and chemicals. Bendamustine, a DNA alkylating agent, used in chronic lymphoid leukaemia, Non-Hodgkin’s lymphoma. Erythema multiformae is a rare, yet serious adverse effect seen with Bendamustine. Case report: This is a case report of a 51 year old female presented with complaints of breathlessness and cough with expectoration for 20 days. She was diagnosed to have low grade stage I Non-Hodgkin’s lymphoma. Patient was started on injection bendamustine. On the second day, patient complained of itchy skin lesions over upper limbs, lower limbs and neck. On examination, tender, palpable erythematous, targetoid skin lesions over the dorsal surface of defined areas were noted. Diagnosis of drug induced erythema multiformae was made. Conclusion: This case illustrates bendamustine, an efficacious and widely used alkylating agent, can induce serious adverse effect like erythema multiformae. However, continuous monitoring is essential in patients on bendamustine for such adverse reactions.

Keywords: Bendamustine, erythema multiformae, target lesions.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More